Aptose Biosciences
APTO
#10445
Rank
ยฃ3.18 M
Marketcap
ยฃ1.25
Share price
0.00%
Change (1 day)
761.84%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -ยฃ16.16 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ18.41 Million, an increase over its 2023 earnings that were of -ยฃ38.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ16.16 Million-12.22%
2024 -ยฃ18.41 Million-51.82%
2023 -ยฃ38.21 Million22.9%
2022 -ยฃ31.09 Million-34.91%
2021 -ยฃ47.76 Million17.36%
2020 -ยฃ40.7 Million107.65%
2019 -ยฃ19.6 Million-7.73%
2018 -ยฃ21.25 Million160.68%
2017 -ยฃ8.15 Million-20.27%
2016 -ยฃ10.23 Million28.71%
2015 -ยฃ7.95 Million
2013 -ยฃ4.51 Million
2010 -ยฃ3.84 Million-8.31%
2009 -ยฃ4.19 Million
2006 -ยฃ7.76 Million-156.93%
2005 ยฃ13.61 M-185.16%
2004 -ยฃ15.99 Million458.58%
2003 -ยฃ2.87 Million-63.66%
2002 -ยฃ7.88 Million-8.04%
2001 -ยฃ8.57 Million16.73%
2000 -ยฃ7.34 Million294.99%
1999 -ยฃ1.86 Million-6.51%
1998 -ยฃ1.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-ยฃ45.82 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-ยฃ49.27 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-ยฃ24.83 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA